SIRT3 and pancreatic neoplasm: These results demonstrate that SIRT3 may play an important role in affecting the sensitivity of pancreatic cancer cells to the KRASG12D inhibitor, and suggest that the down-regulation of SIRT3 by KRASG12D may be an intrinsic mechanism by which pancreatic cancer cells harboring KRASG12D resists its own inhibitor.